Point72 Europe’s GoHealth GOCO Stock Holding History

Point72 Europe’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-667	Closed	-$130K	–	34
2020 Q3	$130K	Buy	+667	New	+$161K	0.08%	29

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Point72 Europe's GOCO Position: Q4 2020 in Review

Point72 Europe sold out of GoHealth (GOCO) in Q4 2020, closing a stake of 667 shares — an estimated $130K sold.

Point72 Europe first reported a position in GOCO in Q3 2020 and held it in 1 quarter. The position peaked at $130K in Q3 2020. 99 funds tracked by Wall St. Rank hold GOCO as of Q4 2020.

Point72 Europe reported no remaining GoHealth position as of Q4 2020 after selling out during the quarter.
Point72 Europe sold 667 GoHealth shares in Q4 2020, an estimated $130K.
Point72 Europe first reported a position in GoHealth in Q3 2020 and held it in 1 quarter.
Point72 Europe's GoHealth position peaked at $130K in Q3 2020.
99 funds tracked by Wall St. Rank held GoHealth as of Q4 2020.

Based on Point72 Europe's 13F filing for Q4 2020, filed 16 Feb 2021.